Progress in the development of pandemic influenza vaccines and their production technologies

por Kiselev, O. I.
Publicado 2010

The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure

por Vasin, A. V., Petrova, A. V., Egorov, V. V., Plotnikova, M. A., Klotchenko, S. A., Karpenko, M. N., Kiselev, O. I.
Publicado 2016

Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein

por Kotlyarov, R.Y., Kuprianov, V.V., Migunov, A.I., Stepanova, L.A., Tsybalova, L.M., Kiselev, O.I., Ravin, N.V., Skryabin, K.G.
Publicado 2010

Recombinant Influenza Vaccines

por Sedova, E.S., Shcherbinin, D.N., Migunov, A.I., Smirnov, Iu.A., Logunov, D.Iu., Shmarov, M.M., Tsybalova, L.M., Naroditskiĭ, B.S., Kiselev, O.I., Gintsburg, A.L.
Publicado 2012

Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents

por Kiselev, O. I., Vasin, A. V., Shevyryova, M. P., Deeva, E. G., Sivak, K. V., Egorov, V. V., Tsvetkov, V. B., Egorov, A. Yu., Romanovskaya-Romanko, E. A., Stepanova, L. A., Komissarov, A. B., Tsybalova, L. M., Ignatjev, G. M.
Publicado 2015